Delivery Order SPE2DB22D9151-SPE2DB25FM8JB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,986.59 by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,892.75 by the Defense Logistics Agency on September 23, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This delivery order was issued without a set-aside designation and carries an ultimate completion date of September 24, 2025. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,814.73 on July 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) to support federal healthcare operations. This firm fixed-price delivery order carries an ultimate completion date of July 8, 2025, and does not utilize a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $8,789.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ondansetron HCl 4 mg tablets (500 count). The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.19 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 8 mg tablets (30-count packages) under a firm fixed-price contract type. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will be executed from Conshohocken, Pennsylvania. This delivery order was not issued under a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency Troop Support Medical. The $2,003.65 firm fixed-price contract is for the delivery of Ondansetron HCl 4mg tablets. The contract has a completion date of February 14, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois. The company holds a separate indefinite delivery contract with the Defense Logistics Agency valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,780.34 firm fixed-price delivery order is for the supply of 4560062223 - Ondansetron ODT 4 MG Tablet 30S, with a completion date of February 28, 2023. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,157.70 for Ondansetron Hydrochloride under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The award, issued on July 28, 2025, with an ultimate completion date of August 7, 2025, represents a discrete ordering action against the company's larger Indefinite Delivery Contract with the...
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB25FM8JBDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1.74K on September 22, 2025, by the Defense Logistics Agency for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This delivery order carries a firm fixed-price structure with an ultimate completion date of September 23, 2025, and was issued without a set-aside designation. The delivery will be performed at the contractor's location in Park Ridge, Illinois, supporting the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.9M and valid through November 2026. This IDC framework enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/22/25 |